Health and Healthcare

Friday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

SEATTLE GENETICS I [SGEN] +11.38%
IMMUNOGEN INC [IMGN] +8.86%
IDM PHARMA INC [IDMI] +8.58%
SUNESIS PHARMACEUTIC [SNSS] +8.55%
SANGAMO BIOSCIENCE [SGMO] +8.52%

Diagnostic Substances

NYMOX PHARM CORP [NYMX] +44.72%
VALERA PHARMACEUTICA [VLRX] +6.03%
HEALTHCARE TECH LTD [HCTL] +5.33%
OSTEOLOGIX INC [OLGX.OB] +5.26%
ICAGEN, INC. [ICGN] +3.78%

Drug Delivery

QUIGLEY CORP THE [QGLY] +3.88%
DELCATH SYSTEMS INC [DCTH] +3.20%
ELAN CP PLC ADR [ELN] +2.35%
HOSPIRA INC [HSP] +0.71%
BIOVAIL CORP [BVF] +0.48%

Drug Manufacturers

ACCESS PHARMACEUTICL [ACCP.OB] +72.00%
ALLOS THERAPEUTICS [ALTH] +9.84%
ALEXZA PHARMACEUTICA [ALXA] +8.09%
MARSHALL EDWARDS [MSHL] +3.62%
PHARMAXIS LTD ADR [PXSL] +3.41%

Medical Appliances & Equipment

SPECTRASCIENCE NEW [SCIE.OB] +22.64%
INTUITIVE SURG INC [ISRG] +17.57%
TRIMEDYNE INC [TMED.OB] +8.55%
VOLCANO CORPORATION [VOLC] +8.05%
REGENERATION TECH [RTIX] +6.78%

Medical Instruments & Supplies

HEMOSENSE INC. [HEM] +12.58% $0
EV3 INC. [EVVV] +12.20% $0
ROCHESTER MEDICAL [ROCM] +11.45% $56.7 M
ATRICURE, INC. [ATRC] +11.45% $8.9 M
MILESTONE SCIENTIFIC [MLSS.OB] +7.89%

Medical Laboratories & Research

BIO-IMAGING TECH [BITI] +4.99%
MEDASORB TECHNOLOGS [MSBT.OB] +4.17%
ALLIANCE IMAGING INC [AIQ] +1.84%
ARRAY BIOPHARMA IN [ARRY] +1.02%
PHARM PROD DEV [PPDI] +0.98%

http://www.biohealthinvestor.com/

Sponsored: Want to Retire Early? Start Here

Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.